Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease

[1]  A. Miccio,et al.  Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion , 2018, Haematologica.

[2]  Leo D. Wang,et al.  HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  A. Vora,et al.  Are the risks of treatment to cure a child with severe sickle cell disease too high? , 2017, British Medical Journal.

[4]  Shannon R. McCurdy,et al.  Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Powell,et al.  Cyclophosphamide improves engraftment in patients with SCD and severe organ damage who undergo haploidentical PBSCT. , 2017, Blood advances.

[6]  J. Kurtzberg,et al.  Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. , 2017, Blood.

[7]  G. Veres,et al.  Gene Therapy in a Patient with Sickle Cell Disease: Brief Report , 2017, The New England journal of medicine.

[8]  M. DeBaun,et al.  Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative , 2016 .

[9]  K. Leung,et al.  A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. , 2016, Blood.

[10]  E. Fuchs,et al.  Allogeneic stem cell transplantation for sickle cell disease , 2016, Current opinion in hematology.

[11]  A. Pickard,et al.  Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  A. King,et al.  Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies , 2015, American journal of hematology.

[13]  E. Meier,et al.  Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia , 2015, Pediatric blood & cancer.

[14]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[15]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  Loren Gragert,et al.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.

[17]  J. Powell,et al.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. , 2014, JAMA.

[18]  I. Yaniv,et al.  Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel , 2014, Haematologica.

[19]  A. Srinivasan,et al.  Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  Richard J. Jones,et al.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. , 2012, Blood.

[21]  D. Manwani,et al.  Stem cell transplant for children with sickle cell anemia: parent and patient interest. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  R. Ware,et al.  Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions , 2012, Pediatric blood & cancer.

[23]  M. Horowitz,et al.  Alternative donor transplantation for aplastic anemia. , 2010, Hematology. American Society of Hematology. Education Program.

[24]  P. Thall,et al.  High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation , 2009, Transplantation.

[25]  J. Tisdale,et al.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium? , 2009, Cytotherapy.

[26]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  D. Bareford,et al.  A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease , 2007, Bone Marrow Transplantation.

[28]  M. Koshy,et al.  Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions , 2001, Bone Marrow Transplantation.

[29]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[30]  E. Vichinsky,et al.  Availability of related donors for bone marrow transplantation in sickle cell anemia. , 1994, The American journal of pediatric hematology/oncology.

[31]  S. Davies,et al.  Bone marrow transplantation for sickle cell disease. , 1993, Archives of disease in childhood.

[32]  C. Stocking,et al.  Bone marrow transplantation for sickle cell disease. A study of parents' decisions. , 1991, The New England journal of medicine.